Taro Pharmaceutical Valuation
| TARO Stock | USD 42.48 0.08 0.19% |
At this time, the company appears to be overvalued. Taro Pharmaceutical has a current Real Value of $38.62 per share. The regular price of the company is $42.48. Our model measures the value of Taro Pharmaceutical from inspecting the company fundamentals such as Operating Margin of 0.11 %, shares outstanding of 37.58 M, and Return On Equity of 0.0261 as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other. Key fundamental drivers impacting Taro Pharmaceutical's valuation include:
Price Book 0.8881 | Enterprise Value 694.4 M | Enterprise Value Ebitda 9.453 | Price Sales 2.5867 | Forward PE 9.8135 |
Overvalued
Today
Please note that Taro Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Taro Pharmaceutical is based on 3 months time horizon. Increasing Taro Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Taro Pharmaceutical Industries is useful when determining the fair value of the Taro stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Taro Pharmaceutical. Since Taro Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Taro Stock. However, Taro Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 42.48 | Real 38.62 | Target 35.0 | Hype 42.48 | Naive 42.75 |
The real value of Taro Stock, also known as its intrinsic value, is the underlying worth of Taro Pharmaceutical Company, which is reflected in its stock price. It is based on Taro Pharmaceutical's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Taro Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Taro Pharmaceutical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Taro Pharmaceutical Industries helps investors to forecast how Taro stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Taro Pharmaceutical more accurately as focusing exclusively on Taro Pharmaceutical's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Taro Pharmaceutical's intrinsic value based on its ongoing forecasts of Taro Pharmaceutical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Taro Pharmaceutical's closest peers. When choosing an evaluation method for Taro Pharmaceutical, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Taro Pharmaceutical Investments |
|
Taro Valuation Trend
Knowing Taro Pharmaceutical's actual value is paramount for traders to make sound investment determinations. Taro Pharmaceutical's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Taro Pharmaceutical's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Taro Pharmaceutical's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Taro Market Cap
Taro Pharmaceutical Industries is currently regarded as top stock in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 975.16 Billion. Taro Pharmaceutical adds roughly 1.6 Billion in market capitalization claiming only tiny portion of equities under Health Care industry.Taro Pharmaceutical Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Taro Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Taro Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Taro Pharmaceutical competition to find correlations between indicators driving Taro Pharmaceutical's intrinsic value. More Info.Taro Pharmaceutical Industries is currently regarded as top stock in price to earning category among related companies. It is currently regarded as top stock in price to book category among related companies fabricating about 0.06 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Taro Pharmaceutical Industries is roughly 16.41 . As of the 1st of May 2024, Price To Book Ratio is likely to grow to 3.72. Comparative valuation analysis is a catch-all model that can be used if you cannot value Taro Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Taro Pharmaceutical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Taro Pharmaceutical's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Taro Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Taro Pharmaceutical and how it compares across the competition.
About Taro Pharmaceutical Valuation
The stock valuation mechanism determines the current worth of Taro Pharmaceutical Industries on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Taro Pharmaceutical Industries. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Taro Pharmaceutical based exclusively on its fundamental and basic technical indicators. By analyzing Taro Pharmaceutical's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Taro Pharmaceutical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Taro Pharmaceutical. We calculate exposure to Taro Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Taro Pharmaceutical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 308.6 M | 235.8 M | |
| Pretax Profit Margin | 0.44 | 0.47 | |
| Operating Profit Margin | 0.44 | 0.46 | |
| Net Profit Margin | 0.38 | 0.39 | |
| Gross Profit Margin | 0.67 | 0.48 |
8 Steps to conduct Taro Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Taro Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Taro Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Taro Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Taro Pharmaceutical's revenue streams: Identify Taro Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Taro Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Taro Pharmaceutical's growth potential: Evaluate Taro Pharmaceutical's management, business model, and growth potential.
- Determine Taro Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Taro Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Taro Pharmaceutical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Taro Pharmaceutical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 37.6 M | |
| Quarterly Earnings Growth Y O Y | 1.782 | |
| Forward Price Earnings | 9.8135 |
Taro Pharmaceutical Current Valuation Indicators
Valuation refers to the process of determining the present value of Taro Pharmaceutical Industries and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Taro we look at many different elements of the entity such as Taro's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Taro Pharmaceutical's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Taro Pharmaceutical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Taro Pharmaceutical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Taro Pharmaceutical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Taro Pharmaceutical's worth.When determining whether Taro Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Taro Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Taro Pharmaceutical Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Taro Pharmaceutical Industries Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Taro Pharmaceutical Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Taro Stock analysis
When running Taro Pharmaceutical's price analysis, check to measure Taro Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taro Pharmaceutical is operating at the current time. Most of Taro Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Taro Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taro Pharmaceutical's price. Additionally, you may evaluate how the addition of Taro Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Taro Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taro Pharmaceutical. If investors know Taro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taro Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.782 | Earnings Share 1.22 | Revenue Per Share 16.252 | Quarterly Revenue Growth 0.129 | Return On Assets 0.0103 |
The market value of Taro Pharmaceutical is measured differently than its book value, which is the value of Taro that is recorded on the company's balance sheet. Investors also form their own opinion of Taro Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Taro Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taro Pharmaceutical's market value can be influenced by many factors that don't directly affect Taro Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taro Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taro Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taro Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.